u/fatima_kowalski
Contributes reviews on supplier material. Based in Funchal.
member · joined 16 Jul 2025
Comments — page 2 of 2
comment on [PSA] receptor is not what most of this community thinks it is in c/glp1science · 3 points · 8 months ago
amylin is not GLP-1, posts conflating them get corrected
comment on [Results] 87 weeks, 25kg, and receptor was the hard part in c/glp1science · 1 points · 9 months ago
rodent gastric emptying tells you what to investigate, not what to expect in humans
comment on 503B vs shortage list — genuinely asking which matters more in c/compounding · 29 points · 10 months ago
the 503A/503B distinction is load-bearing, do not blur it
comment on [Results] 61 weeks on 1.7mg, full numbers, ask me anything boring in c/compounding · 5 points · 11 months ago
The confident tone is doing a lot of work that the evidence is not.
comment on telehealth is the most under-discussed thing in c/progresspics in c/compounding · 36 points · 11 months ago
no pharmacy referral codes, naming is fine, recruiting is not
comment on appetite: the version I wish someone had shown me in week 1 in c/glp1science · 99 points · 1 year ago
amylin is not GLP-1, posts conflating them get corrected
comment on 503B — 15 things I got wrong before I got it right in c/compounding · 61 points · 1 year ago
Titration speed is a side-effect dial far more than an efficacy dial.
comment on tried half-life for 17 weeks. here is what happened. in c/glp1science · 15 points · 1 year ago
That is net peptide content, not purity. Different number, different meaning.
comment on [Results] 7 weeks, 26kg, and mechanism was the hard part in c/glp1science · 1 points · 1 year ago
mechanistic speculation is welcome if flaired as speculation
comment on my hs-CRP moved and I cannot work out whether shortage list is why in c/compounding · 59 points · 1 year ago
the shortage list is temporary, it ends and compounding becomes illegal again
comment on [Discussion] we are measuring telehealth at the wrong time and calling it noise in c/compounding · 31 points · 2 years ago
comment on [Question] Poland — has anyone got a straight answer on 503B in c/compounding · 28 points · 2 years ago
the Germany situation is different from the US, different regulations
comment on tried appetite for 22 weeks. here is what happened. in c/glp1science · 1 points · 2 years ago
receptor distribution matters, GLP-1 is not everywhere
comment on help me understand 503A, I have read the wiki twice in c/compounding · 16 points · 2 years ago
state board rules differ, say which state
comment on Denmark: incretin, and what it actually costs here in c/glp1science · 605 points · 2 years ago
mechanistic speculation is welcome if flaired as speculation
comment on [Lab] SSA survo — Medutest came back 97.4% against a claimed 96.2% in c/compounding · 0 points · 2 years ago
Yeah, 503A and 503B are different regulatory animals.